- Investing Ideas
- /
- Household Healthcare Sector
Household Healthcare Sector
Results
2305
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2305 companies
KALA BIO
Market Cap: US$26.4m
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases.
KALA
US$4.04
7D
10.1%
1Y
-38.0%
Harvard Apparatus Regenerative Technology
Market Cap: US$26.3m
A clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects.
HRGN
US$1.65
7D
-0.6%
1Y
-32.7%
Innovative MedTech
Market Cap: US$26.1m
Through its subsidiaries, engages in the provision of health and wellness services in the United States.
IMTH
US$0.44
7D
-27.2%
1Y
-29.5%
Kun Peng International
Market Cap: US$26.0m
Engages in the distribution of health care and health-related household products through its online platforms in the People’s Republic of China.
KPEA
US$0.065
7D
0%
1Y
-51.3%
CytoMed Therapeutics
Market Cap: US$26.0m
A pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore.
GDTC
US$2.20
7D
-1.6%
1Y
6.4%
Advanced Biomed
Market Cap: US$25.8m
An investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan.
ADVB
US$1.14
7D
-10.2%
1Y
n/a
Scilex Holding
Market Cap: US$25.7m
Focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
SCLX
US$4.55
7D
8.1%
1Y
-88.5%
Daré Bioscience
Market Cap: US$25.7m
A biopharmaceutical company, develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health in the United States.
DARE
US$2.90
7D
0.3%
1Y
-44.6%
Chemomab Therapeutics
Market Cap: US$25.6m
A clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States.
CMMB
US$1.37
7D
-0.4%
1Y
56.9%
ALX Oncology Holdings
Market Cap: US$25.6m
A clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.
ALXO
US$0.46
7D
6.0%
1Y
-96.5%
Generation Bio
Market Cap: US$25.5m
A biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells.
GBIO
US$0.37
7D
-2.9%
1Y
-87.9%
Oncotelic Therapeutics
Market Cap: US$25.2m
A clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications.
OTLC
US$0.065
7D
24.8%
1Y
75.7%
China SXT Pharmaceuticals
Market Cap: US$24.8m
A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.
SXTC
US$1.55
7D
29.2%
1Y
-81.9%
Prescient Therapeutics
Market Cap: AU$38.3m
A clinical stage oncology company, develops drugs for the treatment of various cancers in Australia.
PTX
AU$0.048
7D
-5.0%
1Y
8.0%
iAnthus Capital Holdings
Market Cap: CA$33.7m
Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.
IAN
CA$0.005
7D
0%
1Y
-80.0%
Thiogenesis Therapeutics
Market Cap: CA$33.2m
A biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.
TTI
CA$0.73
7D
-1.4%
1Y
4.3%
MediPharm Labs
Market Cap: CA$33.2m
Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.
LABS
CA$0.075
7D
-16.7%
1Y
-6.3%
Micro-X
Market Cap: AU$37.4m
Designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa.
MX1
AU$0.056
7D
-3.4%
1Y
-38.5%
Starpharma Holdings
Market Cap: AU$37.2m
A biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications worldwide.
SPL
AU$0.089
7D
1.1%
1Y
-19.1%
CalciMedica
Market Cap: US$23.9m
A clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage.
CALC
US$1.80
7D
-10.0%
1Y
-65.4%
BioAtla
Market Cap: US$23.8m
A clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.
BCAB
US$0.39
7D
-2.5%
1Y
-77.2%
Vaso
Market Cap: US$23.7m
Operates in the healthcare equipment and information technology industries in the United States and internationally.
VASO
US$0.14
7D
2.3%
1Y
-48.2%
Doctor Care Anywhere Group
Market Cap: AU$36.7m
Provides digital healthcare and development services in the United Kingdom and the Republic of Ireland.
DOC
AU$0.10
7D
2.0%
1Y
53.8%
Grey Wolf Animal Health
Market Cap: CA$32.5m
Operates as an animal health and wellness company in Canada.
WOLF
CA$0.97
7D
4.3%
1Y
42.6%
Inspiration Healthcare Group
Market Cap: UK£17.5m
Designs, manufactures, and sells medical technology products worldwide.
IHC
UK£0.20
7D
-1.0%
1Y
19.3%
FLUENT
Market Cap: US$23.6m
Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.
FNT.U
US$0.05
7D
0%
1Y
-68.8%
Pulmatrix
Market Cap: US$23.5m
A clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States.
PULM
US$6.81
7D
5.1%
1Y
260.6%
QT Imaging Holdings
Market Cap: US$23.5m
Engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, monitoring, and treatment of diseases in the United States and Internationally.
QTIH
US$0.82
7D
8.6%
1Y
-3.0%
Eagle Pharmaceuticals
Market Cap: US$23.4m
A pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States.
EGRX
US$2.00
7D
3.1%
1Y
-46.5%
OSR Holdings
Market Cap: US$23.3m
A healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea.
OSRH
US$1.16
7D
-0.9%
1Y
-89.2%
Vor Biopharma
Market Cap: US$23.3m
Operates as a clinical-stage cell and genome engineering company.
VOR
US$0.18
7D
-0.2%
1Y
-88.6%
CleanSpace Holdings
Market Cap: AU$35.9m
Engages in the design, manufacture, and sale of respiratory protection products and services for healthcare and industrial markets worldwide.
CSX
AU$0.46
7D
1.1%
1Y
48.4%
Cryosite
Market Cap: AU$35.9m
Provides outsourced clinical trials logistic services in Australia.
CTE
AU$0.73
7D
-3.3%
1Y
-30.0%
NanoViricides
Market Cap: US$23.1m
A clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.
NNVC
US$1.79
7D
27.0%
1Y
-19.7%
Propanc Biopharma
Market Cap: US$23.1m
A biopharmaceutical company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia.
PPCB
US$3.00
7D
2.6%
1Y
-95.4%
Nanalysis Scientific
Market Cap: CA$31.7m
Develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally.
NSCI
CA$0.29
7D
5.5%
1Y
-37.0%